A detailed history of Mcdaniel Terry & CO transactions in Abbott Laboratories stock. As of the latest transaction made, Mcdaniel Terry & CO holds 18,168 shares of ABT stock, worth $2.08 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
18,168
Previous 18,298 0.71%
Holding current value
$2.08 Million
Previous $1.9 Million 8.94%
% of portfolio
0.17%
Previous 0.17%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$100.07 - $118.13 $13,009 - $15,356
-130 Reduced 0.71%
18,168 $2.07 Million
Q2 2024

Aug 05, 2024

SELL
$100.73 - $112.44 $4,029 - $4,497
-40 Reduced 0.22%
18,298 $1.9 Million
Q1 2024

Apr 29, 2024

SELL
$109.52 - $120.96 $143,471 - $158,457
-1,310 Reduced 6.67%
18,338 $2.08 Million
Q4 2023

Jan 24, 2024

SELL
$90.19 - $110.4 $82,072 - $100,464
-910 Reduced 4.43%
19,648 $2.16 Million
Q3 2023

Oct 23, 2023

BUY
$95.53 - $114.62 $301,874 - $362,199
3,160 Added 18.16%
20,558 $1.99 Million
Q2 2023

Jul 21, 2023

SELL
$100.78 - $112.29 $22,877 - $25,489
-227 Reduced 1.29%
17,398 $1.9 Million
Q1 2023

May 05, 2023

BUY
$96.86 - $114.01 $1.71 Million - $2.01 Million
17,625 New
17,625 $1.79 Million
Q3 2021

Dec 06, 2021

SELL
$116.66 - $129.06 $1.71 Million - $1.89 Million
-14,682 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$105.79 - $124.53 $740 - $871
7 Added 0.05%
14,682 $1.7 Million
Q1 2021

May 17, 2021

BUY
$108.84 - $128.23 $761 - $897
7 Added 0.05%
14,675 $1.76 Million
Q4 2020

Feb 12, 2021

BUY
$105.0 - $114.42 $525 - $572
5 Added 0.03%
14,668 $1.61 Million
Q3 2020

Nov 09, 2020

SELL
$91.64 - $111.29 $3,024 - $3,672
-33 Reduced 0.22%
14,663 $1.6 Million
Q2 2020

Aug 13, 2020

SELL
$76.57 - $98.0 $29,249 - $37,436
-382 Reduced 2.53%
14,696 $1.34 Million
Q1 2020

May 08, 2020

BUY
$62.82 - $91.86 $8,292 - $12,125
132 Added 0.88%
15,078 $1.19 Million
Q4 2019

Feb 03, 2020

BUY
$78.51 - $87.4 $549 - $611
7 Added 0.05%
14,946 $1.3 Million
Q3 2019

Nov 07, 2019

BUY
$81.84 - $88.74 $41,492 - $44,991
507 Added 3.51%
14,939 $1.25 Million
Q2 2019

Aug 12, 2019

SELL
$72.88 - $85.0 $49,777 - $58,055
-683 Reduced 4.52%
14,432 $1.21 Million
Q1 2019

May 09, 2019

BUY
$66.22 - $80.06 $53,042 - $64,128
801 Added 5.6%
15,115 $0
Q4 2018

Feb 07, 2019

SELL
$65.56 - $74.27 $9,309 - $10,546
-142 Reduced 0.98%
14,314 $1.04 Million
Q3 2018

Nov 13, 2018

SELL
$60.81 - $73.36 $25,053 - $30,224
-412 Reduced 2.77%
14,456 $1.06 Million
Q2 2018

Aug 13, 2018

BUY
$57.57 - $63.54 $33,275 - $36,726
578 Added 4.04%
14,868 $907,000
Q1 2018

May 11, 2018

BUY
$56.27 - $63.62 $450 - $508
8 Added 0.06%
14,290 $856,000
Q4 2017

Feb 09, 2018

BUY
$53.68 - $57.47 $483 - $517
9 Added 0.06%
14,282 $815,000
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $480 - $536
10 Added 0.07%
14,273 $762,000
Q2 2017

Aug 10, 2017

BUY
N/A
14,263
14,263 $693,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Mcdaniel Terry & CO Portfolio

Follow Mcdaniel Terry & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcdaniel Terry & CO, based on Form 13F filings with the SEC.

News

Stay updated on Mcdaniel Terry & CO with notifications on news.